These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1319987)

  • 1. Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia.
    Yamauchi N; Watanabe N; Maeda M; Okamoto T; Sasaki H; Tsuji N; Tsuji Y; Umeno H; Akiyama S; Niitsu Y
    Jpn J Cancer Res; 1992 May; 83(5):540-5. PubMed ID: 1319987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro.
    Yamauchi N; Kuriyama H; Watanabe N; Neda H; Maeda M; Niitsu Y
    Cancer Res; 1989 Apr; 49(7):1671-5. PubMed ID: 2538230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Implication of hydroxyl radical production in the killing of tumor cells by recombinant human tumor necrosis factor].
    Kuriyama H; Watanabe N; Neda H; Yamauchi N; Maeda M; Niitsu Y
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2967-74. PubMed ID: 2845869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cytotoxicity and suppression of glucose transport rate by combined treatment of recombinant human tumour necrosis factor-alpha and hyperthermia on L929 cells.
    Liong E; Kong SK; Au KK; Li JY; Xu GY; Lee YL; Kwok TT; Choy YM; Lee CY; Fung KP
    Life Sci; 1999; 65(8):PL81-6. PubMed ID: 10466752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis.
    Niitsu Y; Watanabe N; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
    Cancer Res; 1988 Feb; 48(3):654-7. PubMed ID: 2825981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
    Watanabe N; Niitsu Y; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
    Cancer Res; 1988 Feb; 48(3):650-3. PubMed ID: 3335027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
    Haranaka K; Sakurai A; Satomi N
    J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.
    Watanabe N; Yamauchi N; Neda H; Maeda M; Tsuji Y; Okamoto T; Akiyama S; Sasaki H; Tsuji N; Niitsu Y
    Jpn J Cancer Res; 1992 Jun; 83(6):638-43. PubMed ID: 1644666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia against heterotransplanted human prostatic carcinoma and its lymph node metastasis in nude mice.
    Hachiya T; Okada K; Sakurai A; Satomi N; Haranaka K
    Mol Biother; 1992 Mar; 4(1):34-9. PubMed ID: 1627271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of misonidazole, irradiation and hyperthermia on lysosomal enzyme activity in mouse tumours.
    Barratt GM; Wills ED
    Eur J Cancer (1965); 1981 Jan; 17(1):21-8. PubMed ID: 7262145
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
    McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA
    Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.
    Zimmerman RJ; Chan A; Leadon SA
    Cancer Res; 1989 Apr; 49(7):1644-8. PubMed ID: 2924312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence dependence of administration of human recombinant tumor necrosis factor and interleukin-2 in murine tumor therapy.
    Zimmerman RJ; Gauny S; Chan A; Landre P; Winkelhake JL
    J Natl Cancer Inst; 1989 Feb; 81(3):227-31. PubMed ID: 2783463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor necrosis factor-alpha on tumor blood flow and hyperthermic treatment.
    Kallinowski F; Moehle R; Schaefer C; Vaupel P
    Onkologie; 1989 Jun; 12(3):131-5. PubMed ID: 2668835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An in vitro and in vivo study of antitumor effects of rHTNF-alpha on human ovarian cancer].
    Zhao EF; Zhou MQ; Fu CY
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):273-6. PubMed ID: 7805556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effects of intracellular glutathione on hydroxyl radical production induced by tumor necrosis factor.
    Yamauchi N; Watanabe N; Kuriyama H; Neda H; Maeda M; Himeno T; Tsuji Y; Niitsu Y
    Int J Cancer; 1990 Nov; 46(5):884-8. PubMed ID: 2172172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. Implications for mechanisms of action.
    Zimmerman RJ; Marafino BJ; Chan A; Landre P; Winkelhake JL
    J Immunol; 1989 Feb; 142(4):1405-9. PubMed ID: 2915120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful whole body hyperthermia for cancer.
    Rosen P
    Med Hypotheses; 1989 May; 29(1):45-6. PubMed ID: 2747581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.
    McIntosh JK; Mulé JJ; Merino MJ; Rosenberg SA
    Cancer Res; 1988 Jul; 48(14):4011-7. PubMed ID: 3260130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxicity of recombinant human tumor necrosis factor (rHTNF) alone and in combination with chemotherapeutic agents on human ovarian cancer cells].
    Zhao EF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):153-6, 188. PubMed ID: 8354095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.